Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | ICMT | O60725 | 2/20 | 0.31 |
| ▸ | GCGR | P47871 | 1/20 | 0.31 |
| ▸ | HTR1D | P28221 | 1/20 | 0.31 |
| ▸ | HTR1B | P28222 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1690018 | 0.90 | — | — | |
| SCHEMBL12131133 | 0.88 | NR1I2 (0.33) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL15965795 | 0.86 | NR1I2 (0.30) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL14725900 | 0.85 | — | — | |
| SCHEMBL12131134 | 0.85 | ADORA3 (0.39) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL14680876 | 0.85 | — | — | |
| SCHEMBL12131136 | 0.85 | HSD11B1 (0.33) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL12131137 | 0.85 | NPC1 (0.32) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL12131139 | 0.85 | NR1I2 (0.31) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL12131144 | 0.85 | ADORA3 (0.39) | NR1I2EGFRADRA2AADORA3TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170288156-A1 | ORGANIC SOLAR CELL AND METHOD FOR FABRICATING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170288156-A1 | ORGANIC SOLAR CELL AND METHOD FOR FABRICATING THE SAME | STOM, DSG1, XPA | NR1I2 4082/4885EGFR 4486/4885ADRA2A 4858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.